OPRM1 基因 rs1799971(A118G)多态性与曲马多中毒患者临床表现的关联:一项横断面研究
该研究为伊朗一家医院收治的曲马多中毒患者的横断面研究,纳入 83 例未使用其他药物且无癫痫史的患者。OPRM1 A118G 多态性分布为 AA 型 57 例(69%)、AG 型 25 例(30%)、GG 型 1 例(1%)。不良事件包括恶心和/或呕吐 9 例(11%)、头晕 38 例(46%)、癫痫发作 51 例(60%)、需要机械通气的呼吸衰竭 21 例(25%)。OPRM1 A118G 多态性与上述不良事件均无显著关联。作者认为,由于证据有限且不同人群 OPRM1 多态性存在差异,需要更多研究才能得出更明确的结论。
要点
- 83 例曲马多中毒患者中,OPRM1 A118G 基因型分布为 AA 型 57 例(69%)、AG 型 25 例(30%)、GG 型 1 例(1%)。
- 曲马多中毒后严重不良事件常见:癫痫发作 51 例(60%),需要机械通气的呼吸衰竭 21 例(25%)。
- OPRM1 A118G 多态性与癫痫发作、呼吸衰竭、恶心和/或呕吐、头晕均无显著关联。
- 该人群 A 等位基因频率高于 G 等位基因,AA 型比 AG 型更常见,GG 型最少见。
- 作者认为,由于证据有限且不同人群 OPRM1 多态性存在差异,需要更多研究才能得出更明确的结论。
适用人群与场景
- 因曲马多中毒入住伊朗一家医院的患者。
- 患者未使用其他药物或药物,且无癫痫病史。
研究设计与关键结果
- 研究类型为横断面研究,纳入 83 例因曲马多中毒入院的患者,未使用其他药物或药物且无癫痫病史。
- OPRM1 A118G 多态性分布:AA 型 57 例(69%),AG 型 25 例(30%),GG 型 1 例(1%)。
- 不良事件:恶心和/或呕吐 9 例(11%),头晕 38 例(46%),癫痫发作 51 例(60%),需要机械通气的呼吸衰竭 21 例(25%)。
- OPRM1 A118G 多态性与上述不良事件之间无显著关联。
- 该人群中 A 等位基因频率高于 G 等位基因,AA 型比 AG 型更常见,GG 型最少见;这些等位基因比例与其他白种人群相似,但与中国和新加坡人群不同,后者的主要等位基因为 G 等位基因。
证据类型、等级与局限
- 证据类型:横断面研究。
- 局限:作者认为证据有限且不同人群 OPRM1 多态性存在差异,需要更多研究才能得出更明确的结论。
对床旁实践的改变
- 该研究未发现 OPRM1 A118G 多态性与曲马多中毒患者不良结局之间存在显著关联;作者认为由于证据有限且不同人群 OPRM1 多态性存在差异,需要更多研究才能得出更明确的结论。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
INTRODUCTION: The opioid receptor mu1 is a protein coding gene that can have different codes for a protein and may have variations (polymorphisms) affecting how opioids work. The aim of this study was to investigate the prevalence of the most common opioid receptor mu1 polymorphism (A118G) and any relationship between this polymorphism and features following tramadol overdose.
MATERIALS AND METHODS: This was a cross-sectional study of patients admitted with tramadol poisoning to an Iranian hospital. These patients were not taking any other drugs or medications and had no history of seizures.
RESULTS: The results showed that among the 83 patients included in the study, 57 (69 per cent) had the AA genotype, 25 (30 per cent) had the AG genotype, and one (1 per cent) had the GG genotype for the opioid receptor mu1 A118G polymorphism. Nausea and/or vomiting occurred in nine (11 per cent) patients and dizziness in 38 (46 per cent) patients. Serious adverse events included seizures in 51 (60 per cent) patients and respiratory failure requiring mechanical ventilation in 21 (25 per cent) patients. However, there was no significant association between the opioid receptor mu1 A118G polymorphism and these adverse events.
DISCUSSION: In our study, the frequency of the A allele was greater than the G allele, and the AA genotype was more prevalent than AG. The GG genotype was the least common among the polymorphisms of opioid receptor mu1 rs1799971. There was no significant association between the opioid receptor mu1 A118G polymorphism and symptoms in tramadol-poisoned patients. Although these allele proportions are similar to the results reported in other Caucasian populations, they are dissimilar to the findings in Chinese and Singaporean populations. In these Asian studies, the predominant allele was the G allele. It has been suggested that a mutated G allele will decrease the production of opioid receptor mu1-related messenger ribonucleic acid and related proteins, leading to fewer mu-opioid receptors in the brain.
CONCLUSIONS: This study found no significant association between the opioid receptor mu1 A118G polymorphism and adverse outcomes in tramadol-poisoned patients. However, more research is needed to draw more definitive conclusions due to the limited evidence and variability of opioid receptor mu1 polymorphisms in different populations.
参考来源
- Ershad A, Shafiee Dolat Abadi S, Ebrahimian M, et al. Association of the OPRM1 variant rs1799971 (A118G) and clinical manifestations in tramadol poisoned patients: a cross-sectional study. Clin Toxicol (Phila). 2024. PMID: 38946467. doi:10.1080/15563650.2024.2366921
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。